May 2, 2025
The threats and actions to decimate US biomedical research and global health continued this week as the world marked 100 days of the new administration. A proposed $9.3 billion rescission package would codify unprecedented cuts to NIH, USAID, and global health programs. At the same time, a draft NIH policy may halt funding for research outside the US threatening thousands of global collaborations.
As AVAC and partners push back—including at Wednesday’s Senate Appropriations Committee—this moment demands urgent advocacy to protect lives, science, and global stability. Read on for the latest, including new resources and opportunities for defending research, and watch and listen to a powerful new podcast, featuring AVAC’s Mitchell Warren on what it will take to rebuild prevention and global health leadership.
Rescission Package Looms
The US presidential administration is preparing to send Congress a rescission bill that seeks congressional approval to cancel $9.3 billion in already-appropriated funds, including massive cuts to the NIH, the State Department, and USAID. The bill would make recent cuts official—taking back congressionally approved government funding. (The process of “recission” in the US budget process is described in more detail here.) The impact would further dismantle critical programs, including support for HIV treatment and prevention, and vaccine delivery.
Separately, leaked budget documents show plans by the administration to slash NIH’s FY2026 budget by more than 40%, consolidate or eliminate several institutes, and permanently eliminate grants tied to equity and transgender care. It was reported on Thursday that the President will release the full budget on Friday. At a Senate Appropriations Committee hearing this week (see below), Committee Chair Susan Collins, a Republican, called the proposed cuts “very troubling” and warned they would undermine US global leadership in biomedical research.
READ:
- NIH under siege—Science
- Collins says Trump’s research cuts ‘must be reversed’—Politico
- Trump’s Rescissions Would Complete the Decimation of U.S. Global Health Leadership—Public Citizen
Research Matters: Senate Appropriations Committee and NIH Funding
At this week’s Senate Appropriations Committee hearing, Biomedical Research: Keeping America’s Edge in Innovation, lawmakers and witnesses, including the Chief Executive Officer of American Association for the Advancement of Science (AAAS) and Executive Publisher of, Science, Sudip Parikh, pushed back against the threats of further cuts and warned of the devastation of NIH cuts on US scientific leadership, health equity, and economic competitiveness. Democratic Senator Patty Murray, Vice-Chair of the Committee, stressed that slashing funding undermines efforts to develop cures, vaccines, and breakthrough therapies. AVAC and the Federal AIDS Policy Partnership (FAPP) Research Working Group submitted a written statement to the Committee, urging Congress to reject future funding cuts to the NIH and recognize the importance and impact investments in biomedical research have had on lives and livelihoods.
READ:
- Collins and fellow GOP senators speak out in opposition to Trump’s cuts to biomedical research—STAT
- Research Matters – Resources to Protect Research Funding—AVAC
- Written Statement: US Senate Hearing on Biomedical Research—AVAC and FAPP
WATCH:
- Biomedical Research: Keeping America’s Edge in Innovation—Senate Appropriations Committee hearing
NIH Poised to Halt Foreign Research Funding
Internal memos suggest a new policy is expected from the NIH, which would suspend funding for research outside the US. Some NIH staffers have indicated that they have been instructed to pause funds on both new and renewing grants that include research outside the US. The policy could apply to all international collaborations—not just those in “countries of concern”, like China and North Korea—and would impact a wide range of research. According to an exclusive story in Nature, it is unclear when the policy would take effect, and whether it would apply to all research funds to non-US institutions or only ‘subawards’. In 2023, about 15% of NIH grants included foreign partners.
IMPLICATIONS:
Former NIH Director Francis Collins warns the policy could have “tragic consequences,” given the shutdown of USAID and deep NIH budget cuts. Epidemics and diseases like HIV, TB and malaria require global data and partnerships. This new policy would decimate the US’ ability to conduct or support clinical trials and data collection in the countries and communities who need support the most. This would be a stark retreat from decades of US leadership in global science—and could cost millions of lives.
READ:
Protect NIH-Funded Research!
Join the FAPP Research Working Group Advocacy Effort. If you’re ready to take a stand against funding cuts and defend the integrity of evidence-based research, fill out this form. Your voice matters now more than ever.
What We’re Reading & Watching
- WATCH: Resilience and Realignment: Preventing Global Infectious Disease with AVAC’s Mitchell Warren—A Shot in the Arm
- Trump blew up the global fight against AIDS. Can it recover?—Nature
- The end of AIDS is in sight: don’t abandon PEPFAR now—Nature (editorial)
- Will US science survive Trump 2.0?—Nature
- How Trump’s HHS Cuts Are Another Attack On Trans People—Huffington Post
- Scientific Integrity Under Threat: The Role of the IDSA, PIDS, and SHEA Journals in an Evolving Political Landscape—Clinical Infectious Diseases
- How public health has been upended in Trump’s first 100 days—Washington Post
- RFK Jr.’s HHS Orders Lab Studying Deadly Infectious Diseases to Stop Research—Wired
- Bribes and Rationing of AIDS Medicine in Zimbabwe as Trump’s Aid Cuts Bite—Health Policy Watch
- How this Limpopo NGO prepared itself for Trump funding cuts—Bhekisisa
- Three ways to help the developing world survive the end of aid—The Guardian (opinion)
- Supreme Court Heard Arguments on Preventive Health Care Coverage. How’d It Go?—POZ
- KFF Health Tracking Poll April 2025: Public’s View on Major Cuts to Federal Health Agencies—KFF
- The Gates Foundation Grapples With the Age of Donald Trump—The New York Times
Resources
- Politics and Global Health: The Need for a New, Resilient Architecture—AVAC
- Research Matters—AVAC, HIVMA, TAG
- The Trump Administration’s Foreign Aid Review: Status of PEPFAR—KFF
- Scaling Back the Nation’s HIV Response? What the Trump Administration’s HHS Budget May Do—KFF
- Tracking the Freeze: Real-Time Impact on Key Populations—GBGMC
- The Best Investment You Didn’t Know You Made: How NIH Funding Fuels Innovation and Economic Growth—amfAR
Resources for Researchers
AVAC, TAG and the HIV Medicine Association (HIVMA) co-created a new resource hub, Research Matters, to support researchers advocating for sustained NIH funding. These tools include an Advocacy Toolkit to help move our collective efforts forward. We will continue to update the hub with resources to support continued advocacy for biomedical research.